Padraig R Warde, MB BCh, FRCPC

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Keywords: clinical trials, prostate cancer, testicular cancer
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL
A phase I pilot study of pre-operative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes.
Int J Radiat Oncol Biol Phys. 2019 Jan 06;:
Glicksman R, Sanmamed N, Thoms J, Zlotta AR, Finelli A, van der Kwast T, Sweet J, Jewett M, Klotz LH, Rosewall T, Fleshner NE, Bristow RG, Warde P, Berlin A
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
BMC Cancer. 2019 Jan 03;19(1):2
Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, Durbano S, Matthew A, Warde P, O'Neill M, Timilshina N, Segal R, Culos-Reed N
Improving Quality of Radiotherapy Care across Ontario Using a Community of Practice Approach.
Pract Radiat Oncol. 2018 Nov 14;:
Glicksman R, Ang M, Murray E, Simniceanu C, Lockhart E, Gilbert J, Gutierrez E, Warde P
Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
BMC Cancer. 2018 Oct 23;18(1):1031
Alibhai SMH, Ritvo P, Santa Mina D, Sabiston C, Krahn M, Tomlinson G, Matthew A, Lukka H, Warde P, Durbano S, O'Neill M, Culos-Reed SN
The Clinical Specialist Radiation Therapist (CSRT): A case study exploring the effectiveness of a new advanced practice role in Canada.
J Med Radiat Sci. 2018 Jun;65(2):86-96
Harnett N, Bak K, Lockhart E, Ang M, Zychla L, Gutierrez E, Warde P
Gene Expression Signatures Prognostic for Relapse in Stage I Testicular Germ Cell Tumors (TGCT).
BJU Int. 2018 May 03;:
Lewin J, Soltan Ghoraie L, Bedard PL, Hamilton RJ, Chung P, Moore M, Jewett MAS, Anson-Cartwright L, Virtanen C, Winegarden N, Tsao J, Warde P, Sweet J, Haibe-Kains B, Hansen AR
Do radiation oncology outreach clinics affect the use of radiotherapy?
Radiother Oncol. 2018 Feb 22;:
McLaughlin PY, Kong W, de Metz C, Hanna TP, Brundage M, Warde P, Gutierrez E, Mackillop WJ
Serum miRNA predicts viable disease post-chemotherapy in testicular non-seminoma germ cell tumor patients.
J Urol. 2018 Feb 20;:
Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
Eur Urol Focus. 2018 Feb 07;:
Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, Lewin J, Atenafu EG, Sweet J, Anson-Cartwright L, Boström P, Chung P, Warde P, Bedard PL, Bagrodia A, Freifeld Y, Power N, Winquist E, Hamilton RJ

Pages


 
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Professor, Department of Radiation Oncology, University of Toronto​